Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

1. DERN CONTROL POINT INHIBITORS AND THEIR POSSIBILITIES FOR THE THERAPY OF METASTATIC UROTELIAL CANCER

   M.N. Tillyashajhov, С В Камышов, E. P. Bojko

   МақолаBladder and Urothelial Cancer TreatmentsEurasianUnionofScientists20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.002791

2. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

   Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

   МақолаCancer Immunotherapy and BiomarkersClinical & Translational Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.002768